Investor Relations
Corporate Profile
MELA Sciences is a medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations. The company’s flagship product, MelaFind®, is intended to be used when a trained dermatologist chooses to obtain additional information to help decide whether to biopsy certain indeterminate pigmented skin lesions. The FDA has approved MelaFind for use in the U.S. It has received the CE Mark for use in the European Union.
Download Documentation MELA Investor Presentation

For the latest investor presentation please contact Andrew McDonald at

Stock Quote
Last Trade: $1.30*
Change (%): -0.01 (-0.76%)
Volume: 67,600
*minimum 20 min. delay

Webcast - Launch
Q3 2014 MELA Sciences Earnings Conference Call
16:30:00 12 Nov 2014 ET

Webcast - Launch
Q2 2014 MELA Sciences Earnings Conference Call
16:30:00 13 Aug 2014 ET

Webcast - Launch
MELA Sciences Analyst Meeting
08:00:00 13 Aug 2014 ET

Investor Relations Contact Information

Andrew McDonald
LifeSci Advisors, LLC
250 W. 55th Street, #16B
New York, NY 10019

MELA Sciences RSS

Subscribe to MELA Science’s RSS (Really Simple Syndication) feeds to get information delivered directly to your desktop!

Clicking on an RSS link below will provide you with raw XML data of our content. If you do not have a compatible reader installed, you will see XML code in your browser - to view our content, paste the feed address into an RSS reader, or use a browser which supports RSS feeds. See below for additional information on RSS.

MELA Sciences RSS Feeds

Additional Information About RSS
Really Simple Syndication (RSS) is an XML-based format for distributing and aggregating Web content (such as news headlines). Using RSS, web content providers can easily create and disseminate news headlines and URLs. To find more information about common RSS Readers, enter the term “RSS Reader” into an internet search engine.